Clinical Trial Update: Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer

View source ↗

Summary

A clinical trial update indicates that zolbetuximab is being tested in Claudin18.2-positive, HER2-negative advanced gastric cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Zolbetuximab (zolbetuximab)

Snippet

Sponsor: Yonsei University | Conditions: Advanced Gastric Cancer | Status: RECRUITING